Clinical Research Informer

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

JANUARY 17, 2024

The COVID Therapeutics Committee worked with the state health department to develop a policy for fair allocation of scarce medications to treat COVID-19. The first drug that used the new process was Remdesivir in May 2020. Through this work, UPMC learned that allocation does not actually mean receiving the drug.

Clinical Trials

Clinical Trials Clinical Trials Antibody Trials

Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH)

Rethinking Clinical Trials

FEBRUARY 14, 2024

Both drugs have a well-established safety profile and would be a good fit for a pragmatic design. The study started in June 2016 and ended in June 2022 and ultimately found no difference between the 2 drugs in preventing major CV outcomes and non-cancer death among hypertensive VA patients. 45% participants were from rural areas.

Clinical Trials

Clinical Trials Clinical Trials Cardiology Trials

Expert LinkedIn Tips and Tricks for the Pharmaceutical Industry

Pharma Marketing Network

JULY 21, 2023

Use keywords: When you’re filling out your profile, be sure to use relevant keywords throughout. Some relevant keywords to include are: pharmaceutical, drug development, clinical trials, medical research, and healthcare. Join relevant groups: There are thousands of LinkedIn groups dedicated to the pharmaceutical industry.

Sales

Sales Development Clinical Trials Clinical Trials

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

DECEMBER 20, 2023

Yet enrollment of ethnic minorities in NIH clinical trials and for trials studying approved devices and drugs remains low. Approaches from the whole scientific community to tackle the inequality in workforce, trial leadership and trial participants have to be developed. We have to change how we are practicing.

Clinical Trials

Clinical Trials Clinical Trials Trials Cardiology

AI in pharma: Can it be used in DTC?

World of DTC Marketing

FEBRUARY 7, 2021

Drug Discovery and Manufacturing: It helps in the initial screening of drug compounds to the predicted success rate based on biological factors. Precision medicine or next-generation sequencing helps in the faster discovery of drugs and tailored medication for individual patients. . Measuring RNA, DNA quickly.

Doctors

Doctors Doctor Drugs Marketing

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

FEBRUARY 28, 2024

But there are concerns to developing DCTs including lack of standardization and validation, regulatory and ethical uncertainties, engagement vs. coercion, data security and privacy issues, technological literacy and access, resistance to change and adoption, and lack of “safe” sharing. from 2021 to 2026. from 2021 to 2026.

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Research

Working in pharma

World of DTC Marketing

AUGUST 16, 2020

I have seen first hand how the drugs we market can save lives and lead to a better quality of life for millions. When I first started in the industry DTC was fairly new as we launched a number of groundbreaking drugs such as statins. I am critical because I love this industry. Slowly I saw a change within companies.

Sales

Sales Drugs Insulin Development

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

OCTOBER 26, 2023

There are possible clinical research components that would include research on treatment during pregnancy, vaccine development, and implementation model research. A manuscript is under development. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020.

Clinical Research

Clinical Research Clinical Trials Clinical Trials Research

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

AUGUST 28, 2023

Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. The new structure aims to provide clarity and better readability.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

AUGUST 28, 2023

Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. The new structure aims to provide clarity and better readability.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Rethinking Clinical Trials

JULY 6, 2023

The Food and Drug Administration (FDA) issued a draft guidance in May 2023 that provided guidance about the conduct of decentralized clinical trials. This guidance and others in development in other markets act as an important countermeasure to ensuring sustained adoption and implementation of DCTs.

Trials

Trials Clinical Trials Clinical Trials Licensing

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Rethinking Clinical Trials

JULY 13, 2023

The physician-pharmacist team developed recommendations using an algorithm that was supported by the ACC, AHA clinical practice guidelines. Patients went through a screening by a study physician for eligibility.

Clinical Trials

Clinical Trials Clinical Trials Scientist Research

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

NOVEMBER 3, 2023

NAMPT inhibitors are a class of drugs that target the enzyme nicotinamide phosphoribosyltransferase (NAMPT). Despite their potential therapeutic benefits, NAMPT inhibitors have faced several challenges in clinical development. Several trials focused on evaluation of such drugs were discontinued in the past.

Development

Development Drugs Trials FDA Approval

EVERSANA INTOUCH Recognized as a Finalist for Multiple SEO Industry Awards

Intouch Solutions

AUGUST 3, 2022

Among a wide array of tactics and strategies, we’ve been able to actively improve search results for many of our clients using unbranded content to build up visibility in a different area of the community for drugs and the diseases they treat. The Technology: Best Software Innovation . What’s Next? .

Engineer

Engineer Marketing Branding Development

Novel method predicts if COVID-19 clinical trials will fail or succeed

Bioengineer

JULY 21, 2021

In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed. Although drug features and study keywords were the most informative features, all four types of features are essential for accurate trial prediction. . ” ###.

Clinical Trials

Clinical Trials Clinical Trials Trials Engineer

Grand Rounds March 17, 2023: Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePROs) in Oncology (Ethan Basch, MD, MSc)

Rethinking Clinical Trials

MARCH 21, 2023

Goldberg Distinguished Professor and Chief of Oncology Physician-in-Chief, North Carolina Cancer Hospital Director, Cancer Outcomes Research Program University of North Carolina Slides Keywords Patient-reported outcomes, Oncology, Clinical Trials Key Points Symptoms are common in cancer care.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

A New, Automated Approach to Patient Identification for Clinical Trials

ACRP blog

APRIL 25, 2023

Keyword searches, manual reviews, outdated reports, and other time-consuming and expensive methods are commonly used to find eligible candidates for enrollment. Tufts Center for the Study of Drug Development. 2 These delays can be costly, resulting in potential estimated losses of $600,000 to $8 million per day. Impact Report.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Grand Rounds July 21, 2023: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons from IMPACt-LBP (Christine Goertz, DC, PhD; Adam Goode, DPT, PhD)

Rethinking Clinical Trials

AUGUST 28, 2023

The American College of Physicians guideline states that “physicians and patients should treat acute, sub-acute and chronic LBP with non-drug therapies.” People care about this issue, so we feel that developing this evidence is a critical next step to promote change for better care.

Trials

Trials Research Medicine Doctors

Clinical Research Informer

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH)

Trending Sources

Expert LinkedIn Tips and Tricks for the Pharmaceutical Industry

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

AI in pharma: Can it be used in DTC?

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Working in pharma

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

EVERSANA INTOUCH Recognized as a Finalist for Multiple SEO Industry Awards

Novel method predicts if COVID-19 clinical trials will fail or succeed

Grand Rounds March 17, 2023: Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePROs) in Oncology (Ethan Basch, MD, MSc)

A New, Automated Approach to Patient Identification for Clinical Trials

Grand Rounds July 21, 2023: Implementing New Care Pathways for Low Back Pain in Academic Healthcare Systems: Early Lessons from IMPACt-LBP (Christine Goertz, DC, PhD; Adam Goode, DPT, PhD)

Stay Connected